No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review

Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial

(2018) Tadashi Kato et al.   BMC Medicine

Dose Increase Versus Unchanged Continuation of Antidepressants After Initial Antidepressant Treatment Failure in Patients With Major Depressive Disorder

(2018) Lena Rink et al.   JOURNAL OF CLINICAL PSYCHIATRY

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

(2018) Andrea Cipriani et al.   LANCET

OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998–2016

(2018) Helen J Curtis et al.   BMJ Open

Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials

(2017) Markus Dold et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study

(2017) Agnes Dechartres et al.   BMJ-British Medical Journal

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study

(2017) Agnes Dechartres et al.   BMJ-British Medical Journal

Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis

(2016) Toshi A Furukawa et al.   BMJ Open

How can we make the results of trials and their meta-analyses using continuous outcomes clinically interpretable?

(2014) T. A. Furukawa   ACTA PSYCHIATRICA SCANDINAVICA

Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications

(2011) Ni A. Khin et al.   JOURNAL OF CLINICAL PSYCHIATRY

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD

(2008) George I. Papakostas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy

(2008) Henricus G Ruhé et al.   NEUROPSYCHOPHARMACOLOGY